# FDA 483 - IBSA PHARMA INC - August 07, 2025

Source: https://www.keypedia.com/records/483/ibsa-pharma-inc/8fae8400-20d2-4dfa-a873-8a39f1baa834

> FDA 483 for IBSA PHARMA INC on August 07, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: IBSA PHARMA INC
- Inspection Date: 2025-08-07
- Product Type: other
- Office Name: New Jersey District Office
- Summary: An FDA inspection of IBSA PHARMA INC in Parsippany, NJ, revealed a significant issue regarding their Foreign Supplier Verification Program. The firm failed to establish written procedures for ensuring appropriate verification activities for imported food products, including Thirodium, from IBSA Farmaceutici Italia SRL (Italy). This indicates a lack of control over the safety and compliance of imported goods.

## Related Officers

- [Zameer Farouk](https://www.keypedia.com/people/zameer-farouk/3473e87d-9dc5-4daf-b5c7-1f0dec644e9b)
- [Yaaseen A. Hossen](https://www.keypedia.com/people/yaaseen-a-hossen/39d006a9-8477-45dc-a2c8-6764ec5b3858)
- [Willy A. Orantes](https://www.keypedia.com/people/willy-a-orantes/3e88c0f0-fcd6-4ace-a3ee-5aa8190bd97e)
- [Tanvir Kaium](https://www.keypedia.com/people/tanvir-kaium/4efaaf7b-78f1-4bd3-876b-9a9aa0ab3c57)
- [Tamee Kalun](https://www.keypedia.com/people/tamee-kalun/8599e49e-6256-426a-99ec-289e1a884946)

Company: https://www.keypedia.com/companies/ibsa-pharma-inc/64173f42-2e4a-4df0-a5ba-f2ed1affed0b

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248